Viatris Inc. - SIC # 8071 - MEDICAL LABORATORIES

Ticker Exchange SIC # Website Latest Ticker
VTRS Nasdaq 8071 www.viatris.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Viatris Inc.

How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks? - Jun 19th, 2026 7:32 am
FDA Seeks Updated Labeling for Testosterone Therapies - Jun 18th, 2026 3:56 pm
1 Cash-Producing Stock with Exciting Potential and 2 Facing Headwinds - Jun 16th, 2026 7:53 am
Viatris Recognized as One of the 2026 Best Workplaces™ in Canada - Jun 16th, 2026 4:59 am
Viatris (VTRS) Stock And The 58% Undervaluation Debate After A Strong Year Of Returns - Jun 14th, 2026 2:06 pm
Viatris Euro Debt Raise Reshapes Capital Structure And Valuation Story - Jun 14th, 2026 12:05 pm
Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026? - Jun 11th, 2026 8:05 am
3 Generic Drug Stocks to Watch as New Growth Drivers Emerge - Jun 5th, 2026 9:46 am
How Is Zoetis’ Stock Performance Compared to Other Healthcare Stocks? - Jun 3rd, 2026 6:34 am
Opus Genetics Touts Retinal Gene Therapy Pipeline, September BEST1 Data Catalyst - May 25th, 2026 8:02 pm
Assessing Viatris (VTRS) Valuation After FDA Review Acceptance For Fast Acting Non Opioid Meloxicam - May 24th, 2026 9:09 am
1 Unpopular Stock That Should Get More Attention and 2 We Find Risky - May 23rd, 2026 4:28 am
Viatris (VTRS): Buy, Sell, or Hold Post Q1 Earnings? - May 21st, 2026 1:32 pm
Acute Myocardial Infarction Market is Expected to Hit Growth Stride at a CAGR of 13% During the Forecast Period (2026-2036) with New Therapeutic Innovations | DelveInsight - May 20th, 2026 8:01 am
FDA Accepts Viatris' NDA for Fast-Acting Non-Opioid Pain Therapy - May 19th, 2026 9:39 am
1 Stock Under $50 to Target This Week and 2 We Avoid - May 19th, 2026 5:08 am
This Income Fund Just Completely Exited Its $37 Million Stake in Algonquin Power. Why? - May 18th, 2026 2:53 pm
5 Revealing Analyst Questions From Viatris’s Q1 Earnings Call - May 18th, 2026 8:28 am
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain - May 18th, 2026 6:00 am
Does Strong Q1 Results And CFO Transition Change The Bull Case For Viatris (VTRS)? - May 15th, 2026 9:17 am